文献速递血栓与止血

大块与非大块肺栓塞的临床预后比较:一项注册登记队列研究

Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study.
PubMed 文献 · J Thromb Haemost · 2020-12-19

大块肺栓塞占3.5%,抗凝期间大出血风险更高(sHR 1.72),但复发性VTE风险无差异;

要点

  • 大块肺栓塞定义为止诊时收缩压<90 mmHg,占全部PE患者的3.5%。
  • 抗凝期间大块PE大出血风险更高,但复发性VTE风险与非大块PE无差异。
  • 停药后两组复发性VTE风险相似,但复发性PE的致死率大块组更高(11.1% vs 2.4%)。

核心结论

  • 初始PE的血流动力学状态不影响抗凝期间及停药后复发性VTE风险,但可能与复发性PE严重程度相关。

研究设计与样本

  • 大块PE定义为止诊时收缩压<90 mmHg,占3.5%。
  • 采用时间至事件多变量竞争风险模型比较复发性VTE、大出血和死亡风险。

主要发现

  • 抗凝期间,大块PE相比非大块PE大出血风险更高(sHR 1.72,95%CI 1.28-2.32)。
  • 抗凝期间,大块PE与非大块PE复发性VTE风险无差异(sHR 1.15,95%CI 0.75-1.74)。
  • 死亡风险增加仅见于PE后第一个月。

关键数值与推荐

  • 大块PE定义:临床就诊时收缩压<90 mmHg。
  • 抗凝期间大出血sHR 1.72(95%CI 1.28-2.32);复发性VTE sHR 1.15(95%CI 0.75-1.74)。

临床怎么用

  • 大块PE患者抗凝期间应更警惕大出血风险。
  • 大块PE病史者停药后复发性PE致死率更高,需关注复发事件的严重程度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Little is known about the prognosis of patients with massive pulmonary embolism (PE) and its risk of recurrent venous thromboembolism (VTE) compared with non-massive PE, which may inform clinical decisions. Our aim was to compare the risk of recurrent VTE, bleeding, and mortality after massive and non-massive PE during anticoagulation and after its discontinuation. METHODS AND RESULTS: We included all participants in the RIETE registry who suffered a symptomatic, objectively confirmed segmental or more central PE. Massive PE was defined by a systolic hypotension at clinical presentation (<90 mm Hg). We compared the risks of recurrent VTE, major bleeding, and mortality using time-to-event multivariable competing risk modeling. There were 3.5% of massive PE among 38 996 patients with PE. During the anticoagulation period, massive PE was associated with a greater risk of major bleeding (subhazard ratio [sHR] 1.72, 95% confidence interval [CI] 1.28-2.32), but not of recurrent VTE (sHR 1.15, 95% CI 0.75-1.74) than non-massive PE. An increased risk of mortality was only observed in the first month after PE. After discontinuation of anticoagulation, among 11 579 patients, massive PE and non-massive PE had similar risks of mortality, bleeding, and recurrent VTE (sHR 0.85, 95% CI 0.51-1.40), but with different case fatality of recurrent PE (11.1% versus 2.4%, P = .03) and possibly different risk of recurrent fatal PE (sHR 3.65, 95% CI 0.82-16.24). CONCLUSION: In this large prospective registry, the baseline hemodynamic status of the incident PE did not influence the risk of recurrent VTE, during and after the anticoagulation periods, but was possibly associated with recurrent PE of greater severity.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Blondon M, Jimenez D, Robert-Ebadi H, et al. Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study. J Thromb Haemost. 2020. PMID: 33119949. doi:10.1111/jth.15146

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。